BINDING CHARACTERISTICS OF (-)-(R)-2-AMINOMETHYLPYRROLIDINE(1,1-CYCLOBUTANEDICARBOXYLATO)-2-PLATINUM(II) TO DNA, RNA AND PROTEIN MOLECULES IN HELA-CELLS AND ITS LETHAL EFFECT - COMPARISON WITH CIS- AND TRANS-DIAMMINEDICHLOROPLATINUMS(II)

被引:26
作者
AKABOSHI, M
KAWAI, K
UJENO, Y
TAKADA, S
MIYAHARA, T
机构
[1] CHUGAI PHARMACEUT CO LTD,CTR DRUG METAB,TOSHIMA KU,TOKYO,TOKYO 171,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT SURG 1,SAKYO KU,KYOTO,KYOTO 606,JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1994年 / 85卷 / 01期
关键词
DWA2114R; PT-195M-DWA2114R; HELA CELL; MEAN LETHAL DOSE; TARGET VOLUME;
D O I
10.1111/j.1349-7006.1994.tb02893.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HeLa S-3 cells were treated with Pt-195m-radiolabeled (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platinum(II) (DWA2114R) under various conditions, and the relationship between the lethal effect of the agent and the number of platinum (Pt) atoms binding to DNA, RNA and proteins was examined. The values of mean lethal concentration for the cells treated with DWA2114 at 37 degrees C for 1, 2 and 3 h were 137.3, 75.10 and 51.17 mu M, respectively. Cells were treated identically and the numbers of Pt atoms combined with DNA, RNA and protein molecules were determined after fractionation of the cells. In this way, the D-0 values (D-0, dose that would give an average of one lethal event per member of the population), expressed as the drug concentration, were substituted for the number of Pt atoms combined with each fraction. The target volumes, the efficacy of Pt atom to kill cells expressed as the reciprocals of the Do values, were then calculated for each fraction. Our findings suggested that DNA was the primary target molecule for cell killing by DWA2114R. The target volumes for DNA were 3.36 x 10(4), 4.00 x 10(4) and 4.10 x 10(4) nucleotides for 1-, 2- and 3-h treated cells, respectively. The cell-killing effects of DWA2114R were lower than those of cis-diamminedichloroplatinum(II) (CDDP) by factors of 1.54, 1.42 and 2.51 for 1-, 2- and 3-h treatments at 37 degrees C, respectively, in terms of the target volume, while those in terms of the mean lethal dose (D-0) were 14.8, 11.2 and 16.0, respectively. The efficacy of DWA2114R in killing the cells was 2.6 times greater than that of CDDP in the 3-h treatment at 0 degrees C.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 20 条
[1]   THE NUMBER OF PLATINUM ATOMS BINDING TO DNA, RNA AND PROTEIN MOLECULES OF HELA-CELLS TREATED WITH CISPLATIN AT ITS MEAN LETHAL CONCENTRATION [J].
AKABOSHI, M ;
KAWAI, K ;
MAKI, H ;
AKUTA, K ;
UJENO, Y ;
MIYAHARA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (05) :522-526
[2]   DETERMINATION OF THE TARGET VOLUME OF HELA-CELLS TREATED WITH PLATINUM-195M RADIOLABELED TRANS-DIAMINEDICHLOROPLATINUM(II) - A COMPARISON WITH CIS-DIAMINEDICHLOROPLATINUM(II) [J].
AKABOSHI, M ;
KAWAI, K ;
MAKI, H ;
AKUTA, K ;
UJENO, Y ;
ONO, K ;
MIYAHARA, T .
NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (04) :389-393
[3]  
AKABOSHI M, 1987, Annual Reports of the Research Reactor Institute Kyoto University, V20, P150
[4]   STRUCTURE AND ACTIVITY RELATIONSHIPS OF PLATINUM COMPLEXES WITH ANTI-TUMOUR ACTIVITY [J].
BRADDOCK, PD ;
CONNORS, TA ;
JONES, M ;
KHOKHAR, AR ;
MELZACK, DH ;
TOBE, ML .
CHEMICO-BIOLOGICAL INTERACTIONS, 1975, 11 (03) :145-161
[5]   CIS-PLATINUM(II) AMINE COMPLEXES - SOME STRUCTURE-ACTIVITY-RELATIONSHIPS FOR IMMUNOSUPPRESSIVE, NEPHROTOXIC AND GASTROINTESTINAL (SIDE) EFFECTS IN RATS [J].
BROOMHEAD, JA ;
FAIRLIE, DP ;
WHITEHOUSE, MW .
CHEMICO-BIOLOGICAL INTERACTIONS, 1980, 31 (01) :113-132
[6]   TRANSITION-METAL COMPLEXES IN CANCER CHEMOTHERAPY [J].
CLEARE, MJ .
COORDINATION CHEMISTRY REVIEWS, 1974, 12 (04) :349-405
[7]   COMBINED TREATMENT OF RADIATION AND CIS-DIAMMINEDICHLOROPLATINUM(II) - A REVIEW OF EXPERIMENTAL AND CLINICAL-DATA [J].
DEWIT, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (03) :403-426
[8]   CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].
EINHORN, LH ;
DONOHUE, J .
ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298
[9]  
ENDOH K, 1989, ANTICANCER RES, V9, P987
[10]  
FICHTINGERSCHEPMAN AMJ, 1987, CANCER RES, V47, P3000